Share of Cost, Huge Cancer Knowledge Resource Made Public

Friday, Aug. 31st 2012 7:17 AM

Bringing the goal of personalized medicine a step closer, scientists who design anti-cancer treatments and clinical trials now have access to a huge cancer knowledge resource, thanks to a collaboration between industry and academia. A report in the 28 March online issue of Nature describes how the Cancer Cell Line Encyclopedia (CCLE) brings together genome data and predictors of drug response for 947 cancer cell lines. The ultimate cancer treatment is one that matches the right drug to the right target in the right patient. This is the goal of personalized medicine.

Posted on Friday, Aug. 31st 2012 7:17 AM | by Share of Cost | in Share of Cost | No Comments »

Leave a Reply

You must be logged in to post a comment.